Meropenem-pralubactam (Meropenem/FL058)

Meropenem-pralubactam · Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Meropenem-pralubactam (Meropenem/FL058), covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Assess the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Meropenem-Pralubactam (Meropenem/FL058) in China Healthy Adult Participants [Phase 1]

See pricing